Novel Coronavirus Disease and the Current Scenario of the Global Health Emergency

Author(s): Geetanjali Baruah, Jagajjit Sahu*

Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents)

Volume 19 , Issue 3 , 2020

Become EABM
Become Reviewer

Keywords: COVID-19, Novel Coronavirus, pandemic, respiratory ailments, contagious, social distancing.

[1]
Hui, D-S.; Azhar, E.I.; Madani, T-A.; Ntoumi, F.; Kock, R.; Dar, O.; Ippolito, G.; Mchugh, T-D.; Memish, Z-A.; Drosten, C.; Zumla, A.; Petersen, E. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis., 2020, 91, 264-266.
[PMID: 31953166]
[2]
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19)- United States, February 12-March 16, 2020. MMWR Morb. Mortal Wkly. Rep., 2020, 69, 343-346.
[http://dx.doi.org/10.15585/mmwr.mm6912e2]
[3]
Yang, J.; Zheng, Y.; Gou, X.; Pu, K.; Chen, Z.; Guo, Q.; Ji, R.; Wang, H.; Wang, Y.; Zhou, Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int. J. Infect. Dis., 2020, 94, 91-95.
[http://dx.doi.org/10.1016/j.ijid.2020.03.017.]
[4]
Xu, H.; Zhong, L.; Deng, J.; Peng, J.; Dan, H.; Zeng, X.; Li, T.; Chen, Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci., 2020, 12(1), 8.
[http://dx.doi.org/10.1038/s41368-020-0074-x]
[5]
Cascella, M.; Rajnik, M.; Cuomo, A.; Dulebohn, S-C.; Di Napoli, R. Features, evaluation and treatment coronavirus (COVID-19) [Updated 2020 Mar 20]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/
[6]
National Institute of Health. Coronavirus (COVID-19), 2020. Available from: https://www.nih.gov/healthinformation/coronavirus
[7]
Zhang, G.; Pomplun, S.; Loftis, A-R.; Loas, A.; Pentelute, B-L. The first-in-class peptide binder to the SARS-CoV-2 spike protein. bioRxiv, 2020.
[http://dx.doi.org/10.1101/2020.03.19.999318]
[8]
Singh, A-K.; Singh, A.; Shaikh, A.; Singh, R.; Misra, A. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: a systematic search and a narrative review with a special reference to India and other developing countries. Diabetes Metab. Syndr., 2020, 14(3), 241-246.
[http://dx.doi.org/10.1016/j.dsx.2020.03.011]


promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 3
Year: 2020
Published on: 03 September, 2020
Page: [203 - 205]
Pages: 3
DOI: 10.2174/1871523019999200601145931

Article Metrics

PDF: 32
HTML: 1